Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of oral octreotide capsules in controlled acromegaly
NL-OMON48842Phase 3Active, not recruiting
- Sponsor
- Chiasma
- Start
- Aug 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of octreotide in acromegaly, sponsored by Chiasma. Started Aug 2018; status: active, not recruiting.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NL-OMON48842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48842.